Approval · Notice of Compliance 15756 · 2014
EFFIENT: Notice of Compliance 15756
Issued June 26, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 15756
- Date
- June 26, 2014
- Company
- Eli Lilly Canada IncToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New information in pediatric patients
- Therapeutic class
- Platelet aggregation inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EFFIENT | Not yet assigned | — |
Medicinal ingredients
- PRASUGREL HYDROCHLORIDE 10 MG per TAB